Detalhe da pesquisa
1.
Different Genetic Signatures of Small-Cell Lung Cancer Characterize Anti-GABAB R and Anti-Hu Paraneoplastic Neurological Syndromes.
Ann Neurol
; 94(6): 1102-1115, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37638563
2.
Peripheral blood CD56(bright) NK cells respond to stem cell factor and adhere to its membrane-bound form after upregulation of c-kit.
Eur J Immunol
; 44(2): 511-20, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24150691
3.
Niche anchorage and signaling through membrane-bound Kit-ligand/c-kit receptor are kinase independent and imatinib insensitive.
FASEB J
; 28(10): 4441-56, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25002122
4.
Added value of whole-exome and RNA sequencing in advanced and refractory cancer patients with no molecular-based treatment recommendation based on a 90-gene panel.
Cancer Med
; 13(7): e7115, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38553950
5.
Membrane-bound Kit ligand regulates melanocyte adhesion and survival, providing physical interaction with an intraepithelial niche.
FASEB J
; 26(9): 3738-53, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22637532
6.
Ribosome biogenesis-based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group.
Mol Oncol
; 17(1): 27-36, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36370117
7.
Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort.
Cancers (Basel)
; 15(13)2023 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37444551
8.
Netrin-1 blockade inhibits tumor associated Myeloid-derived suppressor cells, cancer stemness and alleviates resistance to chemotherapy and immune checkpoint inhibitor.
Cell Death Differ
; 30(10): 2201-2212, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37633969
9.
A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors.
Commun Biol
; 6(1): 949, 2023 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37723198
10.
Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity.
Nat Genet
; 55(4): 607-618, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36928603
11.
Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition.
Mol Oncol
; 2022 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453028
12.
PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon.
Cancer Discov
; 12(6): 1435-1448, 2022 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35398880
13.
Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models.
Cancers (Basel)
; 13(10)2021 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34069519
14.
Dimerization of Kit-ligand and efficient cell-surface presentation requires a conserved Ser-Gly-Gly-Tyr motif in its transmembrane domain.
FASEB J
; 23(9): 3037-48, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19386768
15.
KIT mutations induce intracellular retention and activation of an immature form of the KIT protein in gastrointestinal stromal tumors.
Clin Cancer Res
; 14(8): 2285-94, 2008 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18413817
16.
GIST with homozygous KIT exon 11 mutations.
Lab Invest
; 88(5): 456-7, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18432212
17.
Effects of endoplasmic reticulum stressors on maturation and signaling of hemizygous and heterozygous wild-type and mutant forms of KIT.
Mol Oncol
; 7(3): 323-33, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23146721
18.
Gene expression patterns of hemizygous and heterozygous KIT mutations suggest distinct oncogenic pathways: a study in NIH3T3 cell lines and GIST samples.
PLoS One
; 8(4): e61103, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23593401
19.
Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas.
Target Oncol
; 8(4): 261-9, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23354874
20.
[Imatinib and solid tumours]. / Imatinib et tumeurs solides.
Bull Cancer
; 95(1): 99-106, 2008 Jan.
Artigo
em Francês
| MEDLINE | ID: mdl-18230575